The store will not work correctly when cookies are disabled.
2-(phenylethynyl)-5,6-dihydrobenzo[d]thiazol-7(4H)-one
ID: ALA2426621
PubChem CID: 53235518
Max Phase: Preclinical
Molecular Formula: C15H11NOS
Molecular Weight: 253.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CCCc2nc(C#Cc3ccccc3)sc21
Standard InChI: InChI=1S/C15H11NOS/c17-13-8-4-7-12-15(13)18-14(16-12)10-9-11-5-2-1-3-6-11/h1-3,5-6H,4,7-8H2
Standard InChI Key: SZGKTGVROKLYCT-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
85.2418 -9.1985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
85.9538 -8.7901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
85.9538 -7.9651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
85.2418 -7.5485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
84.5298 -8.7901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
84.5252 -7.9652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
83.7393 -7.7146 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
83.2580 -8.3847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
83.7466 -9.0493 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
85.2429 -6.7235 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
82.4330 -8.3893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
81.6070 -8.3974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
80.7820 -8.4056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
80.3677 -7.6943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
79.5435 -7.7021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
79.1373 -8.4212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
79.5613 -9.1339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
80.3841 -9.1226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 4 1 0
5 1 1 0
1 2 1 0
2 3 1 0
3 4 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 2 0
8 11 1 0
11 12 3 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 253.33 | Molecular Weight (Monoisotopic): 253.0561 | AlogP: 3.06 | #Rotatable Bonds: ┄ |
Polar Surface Area: 29.96 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.44 | CX LogD: 3.44 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.68 | Np Likeness Score: -0.99 |
References
1. Bartolomé-Nebreda JM, Conde-Ceide S, Delgado F, Iturrino L, Pastor J, Pena MÁ, Trabanco AA, Tresadern G, Wassvik CM, Stauffer SR, Jadhav S, Gogi K, Vinson PN, Noetzel MJ, Days E, Weaver CD, Lindsley CW, Niswender CM, Jones CK, Conn PJ, Rombouts F, Lavreysen H, Macdonald GJ, Mackie C, Steckler T.. (2013) Dihydrothiazolopyridone derivatives as a novel family of positive allosteric modulators of the metabotropic glutamate 5 (mGlu5) receptor., 56 (18): [PMID:23947773] [10.1021/jm400650w] |